Page last updated: 2024-11-02

pamidronate and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

pamidronate has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Pamidronate was well tolerated."1.46Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility. ( Bahi-Buisson, N; Brailly-Tabard, S; Célestin, E; Charles, P; Durand, E; Fontaine, I; Lambert, AS; Linglart, A; Miladi, L; Rothenbuhler, A; Trabado, S; Wicart, P, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambert, AS1
Rothenbuhler, A1
Charles, P1
Brailly-Tabard, S1
Trabado, S1
Célestin, E1
Durand, E1
Fontaine, I1
Miladi, L1
Wicart, P1
Bahi-Buisson, N1
Linglart, A1
Lotan, M1
Reves-Siesel, R1
Eliav-Shalev, RS1
Merrick, J1

Other Studies

2 other studies available for pamidronate and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Calcium; Child; Creatinine; Dipho

2017
Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:12

    Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infant; Osteoporosis

2013